Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Johns Hopkins Genomics, |
RCV001250525 | SCV001425329 | uncertain significance | Nail-patella syndrome | 2020-05-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003373088 | SCV004064675 | uncertain significance | Inborn genetic diseases | 2023-06-22 | criteria provided, single submitter | clinical testing | The c.115C>T (p.P39S) alteration is located in exon 1 (coding exon 1) of the LMX1B gene. This alteration results from a C to T substitution at nucleotide position 115, causing the proline (P) at amino acid position 39 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |